Digital Mammography Market: Hospitals Segment Captured The Largest Revenue Share

 Digital Mammography Industry Overview

The global digital mammography market size was valued at USD 1.23 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 10.26% from 2022 to 2030. The rising prevalence of breast cancer is a key factor projected to fuel the market growth over the forecast period. The following are statistical data for breast cancer:

  • According to the latest statistics reported by the WHO, in 2020, there were about 2.3 million women diagnosed with breast cancer and 685,000 deaths globally.
  • As per the data published by Breastcancer.org, in 2022, in the U.S., an estimated 287,850 new cases of invasive breast cancer are anticipated to be diagnosed in women, along with 51,400 new cases of non-invasive (in situ) breast cancer.
  • According to a Globocan report from 2020, breast cancer was the most common type of cancer, with a prevalence rate of 11.7%. According to the same survey, the five-year estimated prevalence for both sexes indicated that Asia had the highest number of persons affected at 3,218,496 (41.3%), followed by Europe at 2,138,117 (27.4%), and North America with 1.189,111 people (15.3%).
  • According to the WHO, in 2018, around 627,000 women died due to breast cancer globally. It is also estimated that the rate of breast cancer is higher among women in developed regions as compared to developing regions.
  • According to the Cancer Organization India, in 2018, breast and oral cavity cancers accounted for 25.0% of cancer cases in women.

Therefore, such increased prevalence rates of breast cancer are driving the demand for mammography devices.

 


Gather more insights about the market drivers, restraints and growth of the Global Digital Mammography Market

 

The COVID-19 pandemic has negatively impacted the market. The pandemic resulted in substantial reductions in breast cancer screening, cancer management visits, and cancer procedures across the globe. For instance, a study published in the Journal of the American College of Radiology states that in 2020, mammograms dropped to a dramatic low, reducing by up to 92% in some areas in the U.S. Similarly, as per the article published in the Journal of Plastic, Reconstructive & Aesthetic Surgery (Feb 2022), the number of mammograms decreased from 180,813 in 2019 to 160,343 in 2020, which is a decline of 11.3%. Moreover, according to the data from the Centers for Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program, which screens low-income and uninsured women, breast cancer screenings decreased by 87% in April 2020.  This decline in screening volume caused by the COVID-19 presented radiologists with additional challenges, thereby impacting the market growth.

Nevertheless, several physician reports from the U.S. have reported an increase in screening visits during the fourth quarter of 2020, which is likely to continue to rise to pre-covid levels. Furthermore, with the widespread deployment of AI technology, physicians will be able to manage their workload more effectively and precisely, thus eliminating disparities in patient care. Thus, post-pandemic, the number of screening mammography is projected to rise, thereby leading to market expansion in the coming years.

Furthermore, the rising number of breast cancer incidences among the elderly female population is fueling market expansion. For instance, breast cancer is 1.7 times more common in women over 65 than in women 45 to 64 years old, and 10 times more common in women under 45. Similarly, as per a research article published in the NCBI, breast cancer incidence rises with age, from 1.5 occurrences per 100,000 in women 20 to 24 years old to 421.3 cases per 100,000 in women 75 to 79 years old, with 95% of new cases occurring in women aged 40 and above. In addition, the relative survival from breast cancer is reduced among aging women. Thus, the increasing geriatric population is expected to propel market growth in the forecast period.

The introduction of new products in the market is expected to boost the adoption rate among end-users. Substantial improvements in detection and lower recall rates have been the most prominent outcome of DBT adoption. For instance, Hologic's 3D mammography system has been reported to identify 20 to 65% more invasive malignancies than a 2-D mammogram alone. It is FDA-approved and is superior to 2D mammography, particularly for women with dense breasts. Furthermore, the DBT system minimizes false-positive rates, which has the potential to save women not only the emotional toll of unwanted callbacks but also the financial effect on the healthcare system.

Moreover, AI has shown the potential in lowering the amount of time spent on interpretation, which can help alleviate reader fatigue, mitigate the impact of global radiologist shortages, and counterbalance the increased volume of reading caused by DBT image sets. AI will play a significant role in mammography and digital breast tomosynthesis (DBT) ranging from image production, and denoising through risk prediction, cancer diagnosis, and therapy selection, to outcome prediction. Deep learning-based methods outperform traditional computer-aided detection systems based on manually produced features, reaching radiologists' performance for particular tasks. Thereby, such advancements are expected to create lucrative opportunities for key players in the market.

 

Furthermore, a number of major studies have indicated that combined 2D/3D mammography systems are superior to 2D mammography alone in the diagnosis of breast cancer. A large U.S. study of 4,54,850 patients observed that combined 2D/3D Combination screening-detected 5.5 cancers per 1,000 women, compared to 4.3 cancers for 2D screening alone, a 28 percent higher detection rate with combined 2D/3D mammography systems, according to the American Society of Clinical Oncology (ASCO) clinical trial report. Thus, increasing awareness regarding the usage of these systems and high detection rates are the primary factors driving the segment.


Browse through Grand View Research's Medical Devices Industry Related Reports

  • Hair Botox Market - The global hair botox market size was estimated at USD 314.2 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.0% from 2023 to 2030. The growing demand for hair treatment and therapies among women and the rising geriatric population are factors expected to boost the demand for hair botox treatment procedures.

 

  • Sports Medicine Market - The global sports medicine market size was valued at USD 5.08 billion in 2022 and is estimated to grow at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2030. The demand for sports medicine has gained traction in recent years, owing to the rising incidences of sports injuries and growing participation in sports and fitness-related activities by people.

 

Digital Mammography Market Segmentation

Grand View Research has segmented the global digital mammography market based on product, end-use, and region:

Digital Mammography Product Outlook (Revenue, USD Million, 2018 - 2030)

  • 2D Full Field Digital Mammography Tomosynthesis
  • 3D Full Field Digital Mammography Tomosynthesis

Digital Mammography End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals
  • Diagnostic Centers
  • Others

Digital Mammography Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA (Middle East & Africa)

 


Market Share Insights:

  • January 2019: Kiran Medical Systems, the radiology division of Trivitron Healthcare, launched Felicia, a digital mammography system during the Arab Health Convention in Dubai.

  • May 2018: Hologic, Inc. obtained FDA PMA approval for its Clarity HD high-resolution 3DTM imaging and Intelligent 2DTM imaging technologies, which are now accessible on the 3Dimensions breast tomosynthesis system.

 


Key Companies profiled:

Some prominent players in the global digital mammography market include:

  • Hologic Inc.
  • GE Healthcare
  • Koninklijke Philips NV
  • Siemens Healthcare GmBH
  • Fujifilm Corporation
  • PLANMED OY
  • Toshiba Medical Systems
  • Metaltronica S.p.A

 

Order a free sample PDF of the Digital Mammography Market Intelligence Study, published by Grand View Research.


About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.


Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

 

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more